OTHER-2021-053-Settlement Participation Form 2

Browse Search

DocuSign Envelope ID : OCEF2103 -7EB9-465C-9BE7- B11A51EOFFB3 f Thank you for registering your subdivision on the national settlement website and for considering participating in the proposed Settlement Agreement with Johnson & Johnson, Janssen Pharmaceuticals , Inc . , Ortho - McNeil- Janssen Pharmaceuticals , Inc . , and Janssen Pharmaceutica, Inc . ( collectively " Janssen" ) . This virtual envelope contains a Participation Form including a release of claims . The Participation Form in this envelope must be executed, without alteration , and submitted in order for your subdivision to be considered potentially "participating . " The sign- on period for subdivisions ends on January 2 , 2022 . On or after that date , the states ( in consultation with the subdivisions ) and Janssen will determine whether the subdivision participation rate is sufficient for the settlement to move forward . If the deal moves forward , your release will become effective . If it does not, it will not . As a reminder if Y ou . have not already started your review of the settlement Y documentation, detailed information about the Settlements may be found at . https : //nationaloploidsettlement . com/ . This national settlement website also includes links to information about how the Settlements are being implemented in your state and how settlement funds will be allocated within your state , including information about, and links to , any applicable allocation agreement or legislation . This website will be supplemented as additional documents are created . The North Carolina Attorney General ' s Office has also created a state- specific website . It may be accessed here . https : //www . morepowerffilnc . org/opioid- settlements / . If you have questions , please send an e -mail to op ioidsettlementancdoL ogw .